Intravenous immunoglobulin for suspected or proven infection in neonates

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 7, 2013, Pages

  Ohlsson, Arne ^a   Lacy, Janet B ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; OXYGEN; PLACEBO; IMMUNOLOGIC FACTOR;

BRAIN DISEASE; CAUSE OF DEATH; CHILD; CHILD HOSPITALIZATION; CHILDHOOD MORTALITY; DISABILITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOTHERAPY; LENGTH OF STAY; MAJOR CLINICAL STUDY; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN INFECTION; OXYGEN THERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; INFANT; INFECTION; META ANALYSIS; MORTALITY; SEPSIS;

HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; INFANT, NEWBORN; INFECTION; LENGTH OF STAY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS; TREATMENT OUTCOME;

EID: 84891639159     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001239.pub4     Document Type: Review

References (38)

1. Ahmed SS, Chowdhury MAKA, Hoque MM, Begum D, Ahmed ASMNU. Role of intravenous immunoglobulin (IVIG) as an adjuvant in the treatment of neonatal sepsis in preterm babies. Journal of Bangladesh College of Physicians and Surgeons 2006;24:97-104.
2. Christensen RD, Brown MS, Hall DC, Lassiter HA, Hill HR. Effect of neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. Journal of Pediatrics 1991;118:606-14.
3. Erdem G, Yurdakök M, Tekinalp G, Ersoy F. The use of IgM-enriched intravenous immunoglobulin for the treatment of neonatal sepsis in preterm infants. Turkish Journal of Pediatrics 1993;35:277-81.
4. Haque KN, Zaidi MH, Bahakim H. IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis. American Journal of Diseases of Children 1988;142:1293-6.
5. INIS Collaborative Group, Brocklehurst P, Farrell B, King A, Juszczak E, Darlow B, et al. Treatment of neonatal sepsis with intravenous immune globulin. New England Journal of Medicine 2011;365(13):1201-11.
6. Samatha S, Jalalu MP, Hegde RK, Vishwanath D, Maiya PP. Role of IgM enriched intravenous immunoglobulin as an adjuvant to antibiotics in neonatal sepsis. Karnataka Pediatric Journal 1997;11:1-6.
7. Shenoi A, Nagesh NK, Maiya PP, Bhat SR, Rao SDS. Multicentre randomized placebo controlled trial of therapy with intravenous immunoglobulin in decreasing mortality due to neonatal sepsis. Indian Pediatrics 1999;36:1113-8.
8. Sidiropoulos D, Boehme U, von Muralt G, Morell A, Barandun S. Immunoglobulin supplementation in prevention or treatment of neonatal sepsis. Pediatric Infectious Disease 1986;5:S193-4.
9. Sidiropoulos D, Bohme U, von Muralt G, Morell A, Barandun S. Immunoglobulin substitution in the treatment of neonatal septicemia [Immunoglobulinsubstitution bei der Behandlung der neonatalen Sepsis]. Schweizerische Medizinische Wochenschrift 1981;111:1649-55.
10. Chen J-Y. Intravenous immunoglobulin in the treatment of full-term and premature newborns with sepsis. Journal of the Formosan Medical Association 1996;95(11):839-44.
11. Gökalp AS, Toksoy HB, Tũrkay S, Bakici MZ, Kaya R. Intravenous immunoglobulin in the treatment of Salmonella typhimurium infections in preterm neonates. Clinical Pediatrics 1994;33(6):349-52.
12. Haque KN, Remo C, Bahakim H. Comparison of two types of intravenous immunoglobulins in the treatment of neonatal sepsis. Clinical and Experimental Immunology 1995;101:328-33.
13. Mancilla-Ramirez J, Gonzalez-Yunes R, Castellanos-Cruz C, Garcia-Roca P, Santos-Preciado JI. Intravenous immunoglobulin in the treatment of neonatal septicemia [Immunoglobulina intravenosa en el tratamiento de septicemia neonatal]. Boletín Médico del Hospital Infantil de México 1992;49(1):4-11.
14. Weisman LE, Stoll B, Kuesar T, Rubio T, Frank G, Heiman H. Intravenous immunoglobulin (IVIG) therapy of neonatal sepsis. Pediatric Research 1990;27:277A.
15. Weisman LE, Stoll BJ, Kueser TJ, Rubio TT, Frank CG, Heiman HS, et al. Intravenous immune globulin therapy for early-onset sepsis in premature neonates. Journal of Pediatrics 1992;121(3):434-43.
16. Akdag A. Role of pentoxifylline and or IgM enriched intravenous immunoglobulin in the treatment of neonatal sepsis. Washington: U.S. National Institutes of Health, ClinicalTrials.gov 2009; NCT01006499.
17. Alejandria MM, Lansang MA, Dans LF, Mantaring JBV. Intravenous immunoglobulin for treating sepsis or septic shock. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD001090]
18. Baker CJ. New uses of intravenous immune globulin in newborn infants. Journal of Clinical Immunology 1990;10:47S-55S.
19. Baley JE. Neonatal sepsis: the potential for immunotherapy. Clinics in Perinatology 1988;15:755-71.
20. Baley JE, Fanaroff AA. Neonatal infections, Part 2: Specific infectious diseases and therapies. In: Sinclair JC, Bracken MB editor(s). Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992:477-506.
21. Franco AC, Torrico AC, Moreira FT, Sá FP, D'Elia HV, Bernardo WM. Adjuvent use of intravenous immunoglobulin in the treatment of neonatal sepsis: a systematic review with meta-analysis. Jornal de Pediatria (Rio J) 2012;88(5):377-83.
22. Friedman CA, Wender DF, Temple DM, Rawson JE. Intravenous gamma globulin as adjunct therapy for severe group B streptococcal disease in the newborn. American Journal of Perinatology 1990;7:1-4.
23. Haque K. Should intravenous immunoglobulins be used in the treatment of neonatal sepsis?. British Journal of Intensive Care 1997;7:12-6.
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327(7414):557-60.
25. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. www.cochrane-handbook.org, [updated March 2011].
26. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BioMed Central Medical Research Methodology 2005;5:13.
27. INIS Study Collaborative Group. The International Neonatal Immunotherapy Study: non-specific intravenous immunoglobulin therapy for suspected or proven neonatal sepsis: an international, placebo controlled, multicentre randomised trial. BioMed Central Pregnancy and Childbirth 2008;8:52.
28. Jenson HB, Pollock BH. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. Pediatrics 1997;99:e2.
29. Jenson HB, Pollock BH. The role of intravenous immunoglobulin for the prevention and treatment of neonatal sepsis. Seminars in Perinatology 1998;22:50-63.
30. Lacy JB, Ohlsson A. Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: meta-analyses. Archives of Disease in Childhood 1995;72:F151-5.
31. Version 5.1.7. Copenhagen: The Nordic Cochrane Center, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1.7. Copenhagen: The Nordic Cochrane Center, The Cochrane Collaboration, 2012.
32. Shah PS, Kaufman DA. Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD006449.pub2]
33. Stoll BJ, Gordon T, Korones SB, et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. Journal of Pediatrics 1996;129:72-80.
34. Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. Journal of Pediatrics 1996;129:63-71.
35. Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database of Systematic Reviews 1998, Issue 4. [DOI: 10.1002/14651858.CD001239]
36. Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates (Cochrane Review). Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD001239]
37. Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD001239.pub2]
38. Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database of Systematic Reviews 2010, Issue 3. [DOI: 10.1002/14651858.CD001239.pub3]